NEW YORK, Sept. 21, 2014 (GLOBE NEWSWIRE) -- The Rosen Law Firm announces today that a class action lawsuit has been filed on behalf of all purchasers of the securities of PDL BioPharma, Inc. (Nasdaq:PDLI) between November 6, 2013 and September 16, 2014, seeking to recover losses for investors under the federal securities laws.
To join the PDL BioPharma class action, go to the website at http://rosenlegal.com/cases-365.html or call Phillip Kim, Esq. or Kevin Chan, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or kchan@rosenlegal.com for information on the class action.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.
According to the lawsuit, PDL BioPharma and certain of its officers and directors made false and misleading statements and/or failed to disclose that the Company was overstating revenue and understating operating expenses, which mislead investors and artificially inflated the Company's stock price, damaging investors.
A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than November 17, 2014. If you wish to join the litigation go to http://rosenlegal.com/cases-365.html or to discuss your rights or interests regarding this class action, please contact, Phillip Kim, Esq. or Kevin Chan, Esq. of The Rosen Law Firm toll free at 866-767-3653 or via e-mail at pkim@rosenlegal.com or kchan@rosenlegal.com.
The Rosen Law Firm focuses on prosecuting securities class action litigation and actions involving financial fraud. The Rosen Law Firm represents investors throughout the globe.